In this study, gas chromatography-mass spectrometry (GC-MS/MS) based urine analysis of Surti goats was done for estrus specific metabolites during estrous cycle. As there are not much studies that have explored urine metabolomics profiling of estrous cycle in goats, we reviewed whatever scientific literature was available to possibly align them with findings of the present study.
During urine metabolomic studies using GC-MS/MS analysis, standardization of metabolomics workflow is necessary for generating data that is precise and has higher reproducibility. Gas chromatography-mass spectrometry (GC-MS) based metabolomics is ideal for identifying and quantitating small molecular metabolites (<650 Daltons), including small acids, alcohols, hydroxyl acids, amino acids, sugars, fatty acids, sterols, catecholamines, drugs and toxins. The technique often uses chemical derivatization to make these compounds volatile enough for gas chromatography. GC-MS-based metabolomics is a versatile technique that can be used for both targeted and untargeted analysis of metabolites in biological samples. This approach may help to discover novel compounds and metabolic pathways associated with specific biological processes or diseased states. Volatile compounds on GC-MS based metabolomics easily allow integrating targeted assays for absolute quantification of specific metabolites with untargeted metabolomics to discover novel compounds. In the present study, GC-MS analysis revealed a total of 56 compounds which were selected after filtering of data by Interquartile range (IQR). Before subjecting for clustering or multivariate technique, data was preprocessed to handle missing values, normalization and appropriate data transformations (
e.g., log transformation, Pareto scaling) to ensure the data’s suitability for clustering analysis. Data normalization was done by Quantile normalization (Fig 2) followed by Pareto scaling in MetaboAnalyst 5.0.
Pareto scaling basically is a preprocessing technique that makes data more amenable to analysis, as variables with both small and large variances contribute more equitably to overall variation in the dataset. MetaboAnalyst provides various visualization options to explore and interpret the clustering results, such as heatmap plots or principal component analysis (PCA) plots that helps to visualize the clustering patterns and identify sample clusters associated with different experimental conditions.
One-way analysis of variance
Eleven distinct metabolites were found significant using one-way ANOVA by MetaboAnalyst 5.0, suggesting their important contribution in goats across stages of the estrous cycle (Table 1).
Hierarchical clustering
Using MetaboAnalyst 5.0, hierarchical clustering was applied to metabolomics data to explore patterns, relationships and similarities among metabolites based on their metabolic profiles. It may be helpful in revealing underlying structure and similarities in the data, which useful for identifying potential biomarkers or gaining insights into the metabolic changes associated with different experimental conditions. Heatmap of discovered urine metabolites in estrous synchronized Surti goats during proestrus, estrus and diestrus phases are shown in Fig 3.
Upregulation and downregulation of metabolites are mentioned in Fig 4.
Principal component analysis (PCA)
PCA was done to identify underlying patterns, grouping of samples and reveal important features (
e.g., metabolites) driving the observed differences between samples. The scree plot shows that the first 5 principal components explain 59.9% of the total variability in the data (Fig 5).
This suggests that these components are most important for describing the underlying patterns in the data.
Score plots (Fig 6) shows samples in the reduced-dimensional space defined by the principal components.
Samples that are close together in the score plot are more similar in their metabolic profiles. Score plot obtained indicates that there is a clear separation among the phases of estrous cycle (proestrus, estrus and diestrus) based on the metabolomic data. However, there is also significant overlap among the phases, indicating some similarities in the metabolic profiles between different phases.
Partial least squares discriminant analysis (PLS-DA)
Multivariate statistical technique PLS-DA elucidated the understanding how the model discriminated and classified samples into predefined phases of the estrous cycle based on their metabolic profiles of different metabolomes. It generated a two-dimensional score plot describing the clear separation between proestrus, estrus and diestrus phases of the estrus cycle (Fig 7).
The first, second, third, fourth and fifth components of PLS-DA analysis explained 13.5%, 9%, 12.4%, 11.3% and 6.3% variations of all 56 metabolites respectively. Further, the variable importance in the projection (VIP) score in the estrous cycle indicatesthe importance of each metabolite in the PLS-DA model. VIP score on a scale of 1.0-3.0 (Fig 8) is used to identify the most discriminant features (
e.g., metabolites).
These features may serve as potential biomarkers or important variables associated with the studied conditions. Metabolites with the highest VIP values are the most powerful group discriminators. Typically, VIP values >1 are significant and VIP values >2 are highly significant. These metabolites could be further investigated to gain insights into the biological processes that underlie the observed differences between the different stages.
Metabolites with VIP score of more than 1 included three metabolites
viz. methylbut-3-yn-2-amine (2-M-3-Bu-2-am), 6-methyl-3-propan-2-yloxan-2-one (Met-3-propan) and (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a] phenanthren-3-ol (cholesterol) in proestrus phase whereas four metabolites
viz. (4
aR,6
aR,6
bS,8
aR,12
aR,14
aR,14
bR)-4,4,6
a,6
b,8
a,11, 11,14
b-octamethyl-2,4
a,5,6,7,8,9,10,12,12
a,14,14
a-dodecahydro-1
H-picen-3-one (Amyrone), hept-6-enenitrile (6-Hep-1-Nit), 3-hydroxypropyl hexadecanoate (3-H-palmitate) and 2-2-dimethylheptan-3-one (2-2-Di-3-hept) in estrus phase and three metabolites namely [(2S)-2-hexadecanoyloxy-3-hydroxypropyl] hexadecanoate (2-Hexadecanoyl), Heptanedinitrile (Heptanedi) and 3-3-dimethylcyclopentane-1-carboxylic acid (3-3-Di cyclo) in diestrus phase of Surti goats.
Highly significant metabolites (VIP value>2) included two metabolites such as 4-amino-2-hydroxybenzoic acid (2-dieth-4-A-2) and 4-Methylphenol (p-Cresol) that were detected in estrus phase whereas one metabolite
i.e. Bis(2-ethylhexyl) hexanedioate (Hexanedioate) that was identified in diestrus phase of Surti goats.
Following data normalization, one-way ANOVA and post hoc Fisher LSD test of urine metabolites was performed with data obtained for proestrus, estrus and diestrus to identify metabolites that varied significantly in different phases of estrous cycle. Fisher LSD test demonstrated that during estrus p-cresol, 2-2-Dimethyl-3-heptanone and 2-(Diethylamino)ethyl-4-amino-2-hydroxybenzoate were significantly higher than proestrus and diestrus. As compared to proestrus and estrus, hexadecanoic acid-1-(hydroxymethyl)-1-2-ethanediyl ester, benzaldehyde-2-amino and ethanone-1-(2-aminophenyl) were significantly higher in diestrus phase. During proestrus phase,1-heneicosyl formate was significantly higher compared to other two phases. b-Amyrone as well as the trans-9-Octadecenoic acid-pentyl ester were significantly higher during the proestrus and estrus phase as compared to diestrus. 2,5,5,6,8a-Pentamethyl-trans-4a-5,6,7,8,8a-hexahydro-gamma-chromene levels were significantly higher in proestrus than in estrus and significantly lower in diestrus. Among the metabolites identified to be higher in estrus, p-cresol has been reported in mammals with almost similar results. Across mammals, microbial activity is responsible for producing cresols along with aromatic compounds that are metabolized and excreted in urine (Fiege, 2000; De
Preter et al., 2004) in free form as well as conjugated form. p-cresol endogenously is produced from tyrosine by intestinal anaerobic bacteria
(Bone et al., 1976). Even though cresols naturally are present in mammalian urine (
Spiehs and Varel, 2009), there is dearth of studies that link its presence with ovarian activity.
A recent report by
Doshi et al., (2024) suggests upregulation of hydracyrlic acid, 3-bromo-1-propanol and benzyl serine in buffalo urine during estrus phase however most the earlier studies concur the dominating presence of 4-Methylphenol (p-Cresol) in urine during estrus. Volatile phenolic compound pheromone 4-Methylphenol (p-Cresol) in urine considered as pheromone has been reported in animals when they are sexually receptive
i.e., during estrus
(Sudhan et al., 2017). During estrus phase of Murrah buffaloes in both synchronized as well as naturally cyclic, 4-methylphenol (p-Cresol) was present in urine
(Muniasamy et al., 2017). Its high concentration in female buffalo urine during estrus period has been reported by
Rajanarayanan and Archunan (2011). Presence of this pheromone has also been established in deer
(Whittle et al., 2000) and mare
(Buda et al., 2012) during period of sexual receptivity. Its role as an indicator of estrus is bolstered by reports of its presence in other biological samples such as saliva
(Karthikeyan et al., 2014) and faeces
(Karthikeyan et al., 2013). Beyond acting as an attractant, it is also suggested to stimulate neuroendocrine pathways for enhanced libido as well as increase in sperm count in male buffaloes (
Archunan and Rajanarayanan, 2010) and influence penile erection in stallion
(Buda et al., 2012). Its increased presence could also be reasoned by its antimicrobial activity in genital region
(Morris et al., 1979) during sexual activity. Some reports also suggest the presence of 4-methylphenol (p-Cresol) not only in estrus but during diestrus in dog urine (
Divya, 2012).